Article Text

Download PDFPDF

P276 Cardiovascular safety of extrafine single inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide in copd: results of safety analysis from the trilogy and trinity studies
Free

Abstract

The research was funded by Chiesi Farmaceutici S.p.A.

M Scuri, I Montagna, C Francisco, G Cohuet, S Vezzoli, A Muraro and S Petruzzelli are employees of Chiesi Farmaceutici S.p.A.

J Vestbo has received honoraria from AstraZeneca, Boehringer-Ingelheim, Chiesi, GSK and Novartis.

D Singh has received honoraria from Apellis, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Genentech, GlaxoSmithKline, Glenmark, Johnson and Johnson, Menarini, Mundipharma, Novartis, Peptinnovate, Pfizer, Pulmatrix, Skypharma, Teva, Therevance and Verona.

M Corradi has received honoraria from Chiesi.

A Papi reports grants, personal fees, and/or reimbursement of travel expenses from Astrazeneca, Chiesi, Boehringer Ingelheim, GlaxoSmithKline, Menarini, Merck Sharp & Dohme, Mundipharma, Novartis, Teva, Sanofi, Zambon.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.